StockWatch
·
Pharmaceuticals
Board Meeting30 Apr 2026, 06:03 pm

Amrutanjan Board to meet May 8 for FY26 results & final dividend

AI Summary

Amrutanjan Health Care Ltd has announced that its Board of Directors will hold a meeting on May 8, 2026, via video conferencing. The key agenda items for this meeting include the consideration and approval of the audited financial results for both the quarter and the full financial year ended March 31, 2026. Additionally, the board will discuss and recommend the final dividend for the financial year 2025-26. In accordance with SEBI regulations, the trading window for the company's equity shares is currently closed, effective from April 1, 2026, and will remain closed until May 10, 2026.

Key Highlights

  • Board meeting scheduled for May 8, 2026.
  • To consider and approve Q4 and FY26 audited financial results.
  • To recommend final dividend for the financial year 2025-26.
  • Trading window closed from April 1 to May 10, 2026.